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Abstract
THE USE OF COMPUTERIZED DYNAMIC POSTCIRC'GRAPHY TO ASilESS Ti-!E
BALANCE IN INDIVIDUALS WITH PARKIP 'SON'S DISEASE
By Theresa Erin McGuirk, RS
A thesis submitted in partial fulfillment of the requirenner.t,; for the degree o".'Maste~ of
Science of Biomedical Engineering at Virginia Coi-(imonwealthUnive:.,;ity.
Virginia Commonwealth Univasit;, ,2005
Major Director: Dr. Peter S . Lum
Associate Professor, Department of Biomedical Engineering

Postural instability is one of the hallmarks of Parki~.rson'sdisease (PD), currently
evaluated using several subjective tools. However, the nature and degree of the resul1.ing
balance deficit is not well specified by these tools. Comp~irerizeddynamic
posturography (CDP) provides an objective assessment by isolating and quanrifying
sensory and motor contributions to balance control. The purpose of this study was to
compare balance in individuals with PD to a control p u p using CDP (NeuroCom Srnart
Balance

aster system). Testing took place at the Southeast Parkinson's disease

Research Education and Clinical Center (PADRECC), an interdisciplinary cel~terof
excellence for people with PD within a Veterans Affairs Medical Center. The 5 1 PD
patients (mean age = 72.18 k 6.98 years;) were compared to 55 age-matched controls

xi

supplied by the CDP manufacturer. Subjects were assessed with three test scales defined
by the Smart Balance aster@ system: Sensory Organization Test (SOT), Adaptation
Test (ADT), and Limits of Stability Test (LOS). All PD population CDP scores were
significantly different (a=0.05) than those of a healthy population, except for the SOT
Solnatosensory subs&le (p=d.B), LOS Directional Control subscale (p=0.08), ADT
Toes Up subscale (p=O. 16) and ADT Toes Down subscale (p=0.23). The Smar'i Balance

aster@ system's LOS Movement Velocity, Endpoint Excursion, Maximum Excursion,

. :f;
an'dsReaction Time shbscores and the SOT Composite, Visual, and Vestibular subscores

uniquely describe the varying symptoms of the disease. These disease specific
abnormalities may provide insight into focused treatment intervention strategies.

CHAPTER 1: INTRODUCTION

Parkinson's disease (PD) is a progressive neurodegenerative rnovemc-7 t disorder
associated with a loss of dopaminergic nigrostriatal newiis. An estimated : .5 mil:ion
Americans are affected by PD with 20 new cases per 100,GO people per year.

''The

I

,ur

primary symptoms of PD are tremor, rigidity, bradykinssia, and postural instabijity.
Postural instability usually occurs in the late stages of the disease, as a result (\Fincrezsed
extremity and truncal tone, motor incoordination, and dystonomia. More than 35?/:, of
people with advanced PD experience falls and 18% sustain fractures as a r e s ~ l of
t these
falls. 86
There is no cure for PD, but symptoms can be managed using medicine, surgery
and rehabilitative physical therapy. Once PD is diagnosed, the gold standard of present
therapy is the drug levodopa (L-3,4-dihydroxyphenylalanine). L-dopa is used by nerve
cells in the brain to make dopamine. L-dopa is effective in approximately 75%; of
patients diagnosed with PD.

Other medications include Bromocriptine, Selegiiine,

Anticholinergics, and Amantadine.

When medication is not found to be effective,

surgery is sometimes used to reduce PD symptoms.

Procedures such as

cryothalamotomy and thalamic stimulation are used to affect the area found to produce
tremor in the body. 69

it can improve body strength -and balance helping PD patients overcome gait problems.
Just as importantly, exercise gives the PD patient a sense of accomplishment and
freedom

1.1. A Rationale for this Study.
.

Postural instability is one of the hallmarks of Parkinson's disease, even in the
.'>,

early stages of presentation. The inability to maintain balance predisposes afl'ected PD
.(

patients to a loss of equilibrium and falls leading to more disability. 9147 Researcllers have
i.

reported that 38-68% of individuals with PD had fallen in the recent past and 13% fell
more than once a week.

Prior studies have found that balance impairment is a primary

49397

risk factor in the occurrence of falls.

11,15,60,66,80,88,96

Further, PD patients w-alk with

!'

significantly reduced speed and mean step length compared to control subjects.

12,75

Based on these studies, the accurate assessment of postural instability is a significant
-

issue for the PD population. Interestingly, despite the high prevalence of PD and the
severity of the functional limitations resulting from balance deficits, there is little
agreement among health professionals about the most appropriate tools with which to
quantify this impairment.

1.2. Tools Currently Used to Measure Postural Instability in the PD Population.
There are several measurement tools used in clinics as well as research when
evaluating a PD patient.

3
The retropulsion test, which measures a patient's ability to recover equilibrium

after sudden pulling backward on the shoulders, has been suggested as the most valid test
for postural stability in Parkinson's disease.

However, this test is subjective and no

standard method of administration exists.
The Hoehn and Yahr Rating Scale 28.63.78 and the modified Schwab and Englend
Capacity for Daily Living Scale 28,44v33 are also frequently used to evaluate the impact of
Parkinson's disease, but do not directly assess postural instability.
Two current tools are discussed in detail below: The Unified Parkinson's Disease
Rating Scale (UPDRS) and the Berg Balance Scale (BBS). While these methods of
measuring functional impairment in Parkinson's disease exist, at present no 'gold
standard' exists for assessing postural instdbility.

1.2.1. The Unified Parkinson's Disease Rating Scale (UPDRS).
The UPDRS is currently the most widely accepted scale for measuring the
components of PD.

28.32.33

available at the time.

28

It was developed in 1987 by combining the PD rating scales

The UPDRS is used in clinical research and drug trials to follow

the longitudinal course of PD. 28.43.58
The UPDRS is divided into four subscales, including 1) Mentation, Behavior, and
Mood, 2) Activities of Daily Living, 3) Motor, and 4) Complications of Therapy
[APPENDIX A]. In its entirety it provides an overall assessment that quantifies all the
motor and behavioral aspects of the disease. The motor component (UPDRS-111) has
been used to assess postural instability. 28.43.72.73.79.87 UPDRS-111 evaluates 14 items with 27

4
distinct functions. Each item is scored on a scale of 0 to 4. A total of 108 points is
possible, with 108 representing maximum (or total) disability and 0 representing no
disability.

1.2.1.1. UPDRS Validity.
The UPDRS is one of the most evaluated, valid and reliable scales currently
available. 78 Several studies have investigated the structure and meqsurement capabilities
of the UPDRS and have f o q d a high inter-rater consistency.

61387

A videotape of the

UPDRS motor exams bas also. been found to be useful when diagnosing PD, contributing
to the validity of the scale. "*''

1.2.1.2. UPDRS Reliability.
The inter-rater 55,85 and intra-rater 55,78 (test-retest) reliability of the UPDRS scale
has been examined and shown to be a highly reliable measurement of PD. Intra-test
reliability of UPDRSm has also been studied and found to possess a high test-retest
reliability. 55,64

1.2.2. The Berg Balance Scale (BBS).
The Berg Balance Scale is an objective measure of balance abilities. It has been
used to identify and evaluate balance impairment.

2741.51.52353359.72*73380081383

The BBS has also

been used to validate other scales including the Activities-specific Balance Confidence
(ABC) scale,

l3

the Lower Extremity Motor Coordination Test (LEMOCOT),

23

the

5
Dynamic Gait Index (DGI), 9 h d several hnctional balance tests used on post-stroke
patients. 89
The BBS is a detailed balance examination that evalilates 14 tasks colrimon to
everyday life. The items test a subject's ability to maintain pasitions or movements of
increasing difficulty by diminishing the base of support from ~i tting to standing to singleleg stance [APPENDIX B]. One's ability to change positions rs also assessed. Eoch item
is scored on a scale of Oqto 4. A total of 56 points is po::sible, with 0 repr,senting
maxinium (or total) disabilizy and 56 representing no disabilitt .
#

,

1.2.2.1. BBS Validity.
The BBS has recently been demonstrated to be a valid measure of bala.lce and
disease severity in PD as well.

4,5377

Although the scale has been validated nirmerous

times, one recent study performed on a chronic stroke population found the BHS to be
unclear and recommend caution when interpreting BBS score.. It is suggested clinicians
who want to determine fall risk look at reactive balance as o p p s e d to walking baiance. 4 .
Improvements on the condensed item-rating categories of [he BBS have also beern
suggested.

1.2.2.2. BBS Reliability.
The inter-rater and intra-rater (test-retest) reliability of the BBS scale has been
examined and shown to be a reliable measurement of PD. 5"82

6

1.2.3. Computerized Dynamic Posturograpllv (CDP)
Computerized dynamic posturogrnphy (CDP) is defined by the American
Academy of Otolaryngology-Mead and b i x k Surgery and the American Acakmy of
Neurology as a system which "isolates anc quantifies sensor:/ and motor contributions to
balance control and assesses sensorimo ar integration
abno'rmal sensorimotor skills."

ill

people with noi-rnzl and

In 200<, the American Medical Associatio:r added

posturography as a criteria method for doc1 mentation of disability and impairrner;:.

21

: CDP systems were designed to ej aluate and trair, static and dynamic balance
performance.

56,68.91

The designs, once validated, provide afi objective assessmen; of the

sensory and voluntary motor control of balmce with visual biofeedback on either a stable
or unstable support surface and in a stable 3r dynamic visual environment. 67 CIjP is the
only method validated by controlled researcli studies to isolate the fbictional
contributions of vestibular inputs, visual i: .?uts, scmatosensory inputs, central integrating
mechanisms, and neurornuscular system o1 :puts fur postural and balance control.

"" CDP

systems have allowed clinicians to objr :tively measure the postural comporlents of

balance

1.3,7,14.15,16,17,18,1?,22,26,29,36,3:,39,40,42,4- 16,65,92,95

and are able to differentiate between

elderly fallers and non-fallers. 93
CDP is more effective than standard diagnostic tests in differentiating between
PD and PSP in their early stages. 74 Early differentiation improves outcome, because PSP
patients do not respond well to dopaminergic medication. In its early stage, PSP is often
mistaken for PD. CDP (NeuroCom'sa EquiTest system) has been shown to be the only

7
I

test that quantified differences in sensory impairments among idiopathic bilateral
vestibular loss (BVL) patients. 84
CDP (NeuroCom'sq EquiTest system) has demonstrated the ability to describe the
neuro-otological abnormalities associated with dizziness ant1 was the most sensitive
diagnastic test for identifying abnormality in dizzy patient population. 99
CDP has also shown the ability to detect malingering: the false or exaggeration of
a physical or mental diseaSe in order to obtain money, drugs, or evade duty or criminal
responsibility.34 The systems have been used to document posturographic evicence oil
nonorganic sway patterns; identifying patients exaggerating sway f?om thcse with
balance disorders for which<treatment was medically necessary. "0.31

. CDP has also demonstrated the ability to identi@ athletes with pcor ankle
strategy, effectively predicting those athletes likely to suffer ankle sprains duuing the
..I

course of a season. 62
CDP can play an important role of the function evduation and managemexlt of PD
patients and offers the opportunity to more objectively evaluate the nature and degree of
postural instability in PD.

1.2.3.1. CDP Validity.

Controlled research studies have shown CDP to be the only method validated to
isolate vestibular inputs, visual inputs, somatosensory inputs, central integrating
mechanisms and neuromuscular system outputs. 6,7.8 1

8

1.2.3.2. CDP Reliability.
The test-retest reliability of CDP has been measured on several different systems
such as NeuroCom'sa ProBalance Master 25 and NeuroCom'sa Smart Balance Master

54

systems.

20

The measurements evaluated on these systems have sl~ownreliability

although it is suggested that clinicians use caution when interpreting CDP scores.

1.3. Obiectives for this Studv.
This study was designed to identify the clinical utility and validity of
computerized dynamic posturography; using the NeuroComa Smart Balance Master
system as a to,ol used to quantify a balance deficit. There are two objectives for this
'

study:
1) Determine whether PD patient population scores produced by the Smart
Balance Master system are significantly different than those of a typical
healthy population, demonstrating that the Smart Balance Master03
(SBM) system is capable of describing the balance characteristics of a
typical idiopathic PD patient population.
2) Determine which SBM scores have a strong correlation with currently
accepted measures of postural instability among the PD patient
population: the UPDRS and BBS.
/

CHAPTER 2: THE SMART BALANCE MASTER@SYSTEM

The Smart Balance aster@ (SBM) system is a computerized dynamic
posturography (CDP) system designed to assess a patient's balance or provide balanceretaining therapy, (Figure 1). The system provides visual feedback to a patient on either
a stable or unstable support surfsce and in a stable or dynamic visual environment,
(Figure 2). Version 8.2 was used in this study.

Figure 1. The Smart Balance Master system.

9

Figure 2. Moving surface and moving surround. (Courtesy of ~euroCom@
International, Inc.)

2.1. NeuroCom InternationaL Inc.

The Smart Balance Mastea (SBM) system was designed by NeuroCom
International, Inca, a company founded by Lewis Nashner in 1984. The company works

in the development of computerized tools for the assessment and rehabilitation of patients
with balance and mobility disorders.
NeuroCom International, Inc.
9570 SE Lawnfield Road
Clackamus, Oregon 97015
1-800-767-6744 Tel
1-500-653-1991 Fax
www.onbalance.com

2.2. Specifications of Electrical and Mechanical Components.
The SBM system utilizes a dual forceplate, (Figure 3). The forceplate consists of
two 9" x 18" footplates which are connected by a pin joint. The footplates are supported
by four strain gauges, which are mounted on a supporting center plate. A ffih transducer

is attached to the center plate directly beneath the pin joint.

Figure 3. Dual forceplate configuration. (Courtesy of ~ e ~ r o ~ oInternatlljnal,
m*
Inc.)

The five strain gauges transduce force. The center strain gauge, located directly
below the pin joint measures shear forces along the y-axis. The y-axis is considered the
plane parallel to the floor. The other four strain gauges measure vertical force applied
directly to the forceplate. The pin joint, mentioned earlla-, is used to allow the vertical
forces to be measured separately on the right and lei3 footplates.

Each transducer

requires a separate differential amplifier to conditior~the outpub.
characteristics of the forceplate transducers are listed in Table 1.
Table 1. Electrical characteristics of forceplate transchpcers.
25 mV/lb (55V/ke)
Sensitivitv
Calibration
0.1 lb (45 g)
Gain
0.1 lb (45 g)
zero
Gain Temperature Coefficient 0.01 lbPC (4.5 g/T)
0.01 lbPC (4.5 &PC)
Gain Zero Coefficient
0.05 lb (2.3 E)
Linearitv
Output Range
1 175 lb (79.4 kg)

The electrical'

2

-

The forceplate is -moved by two long-life direct-current instrumentation

;;&ornotors

in response to command signals from the computer, (Figure 4).
Current Amplifier
Dual Forceplate

-

Computer

Optical Position

I

1

Figure 4. Flowchart representing the Smart Balance Master system coilecting and recording data.
:.c.
:.,
. ..

Ball bearing .gears provide approximately 95 percent of the motors' power to the
forceplate surface.:qptations. The gear ratio for the two servomotors to forceplate turns is
2{2:1. The gear ratio for the two servomotors to the irisual surround turns is 840:l. Each

sepomotor is powered
.
by a separate linear direct current amplifier. Rotational positions
,a

of&e servomotors are measured by optical position encoders and controlled by separate
feqdback circuits. The performance characteristics of the servomotors are listed in Table

Table 2. Performance characteristics of the two servomotors.
Tilt
1 deglvolt
Output sensitivity
*10 deg
Range
Maximum velocity
50 deglsec (at 4 deg rotate)
Time to maximum velocity 50 msec
Maximum torque (static) 1 200 ft-lb (271 J)
Visual surround tilt
1 deglvolt
Output sensitivity
Range
*10 deg

13
The data is collected at a sampling rate of 100 Hz and recorded using a 2ndorder

Buttenvorth filter with a 12-bit resolution. The cutoff frequency is 0.85 Hz.

2.3. Calculation of Surface Forceplate Measurements.

~.SBM system measures and calculates five dirferent forces, which the patient

. The
f

exerts an the dual forceplate. These five forces are the total vertical force (Fv), total
'

horizolital force (Fh), lateral center of vertical force (Px). left AP y-axis center of vertical
force ( P ~ L )and
, Aght AP y-axis center of vertical force (PyR).
Fv is the subject's weight.

It is measured by the four corner transducers

(described previously) and then calculated by summing them together.

The corner

transducers are described as RF (right front transducer). RR (right rear transducer), LF
'(left front transducer) and LR (left rear transducer).
Fv=RF+RR+LF+LH

Equation I.

;Fh is measured directly by the center force transducer.
The SBM system creates a hypothetical point on tlie forceplate. This point is a
vertical projection of the patient's center of gravity onto the dual foroeplate at any given
instant in time. Px is the distance between this hypothetical point and the y-axis. There
are 4.00 inches between each of the force transducers and the y-axis.
Equation 2.

Py is the distance between the hypothetical point and the x-axis. There are 4.20
inches between each of the force transducers and the x-axis.

Py =

[(LF+ RF) - LR + RR)]
* 4.20
LF+RF+LR+RR

Equation 3.

The SBM system calculates the components of Py. PyL is the left component of
the distance between the hypothetical point and the x-axis.
PyL = LF - LR * 4.20
LF + LR

Equation 4.

PyR is the Aght component of the distance between the hypothetical point and the
x-axis.
PyR = RF -RR * 4.20
RF+RR

Equation 5.

2.4. Calculation of Center of Gravity Measurements.

To calculate the center of gravity (COG) of the sui>ject,the following references
were used, (Figure 5). Experimentally, in the upright starlce, a subject's COG is
positioned at a height 55% of the total height of the subject and 14%of the foot length in
front of the medial malleolus bone in the ankle joint. This positicjns the COG at an
inclined angle of 2.3" forward from the vertical line passivlg through the ankle joint.

Figure 5. Illustration of center of gravity and center of foot p1ac:ement. (Courtesy of ~ e u r o ~ o r n ~
International, Inc.)

2.5. Calculation of the COG Sway Angle.
The SBM system software computes 8, (Figure ci), using values of PCoG and

HCOG,(Equation 6).
..:

Equation 6.

Figure 6. Geometric relationship between 0 and Py. (Courtesy of ~ e u r o ~ oInternational,
rn~
Inc.)

CHAPTER 3: DATA COLLECTI(.!'d MH'HODS

The author began data collection by recruiting ~bjects,for this study from the
PADRECC patient list. Admissible subjects must have :en diagnosed with Parkinson's
disease, be able to stand without the use of an assis!. Je dev'ce and not suffer from
dementia. In general, this limited testable subjects to patienis with mild Parkinson's
disease.

The diagnosis of PD was confirmed by tk: : PAD-?ECC neurologist (i.e.,

appropriate clinical findings, and confirmed responsiv:,~~ess
to jopamine or dopamineagonists), and all participants were ambulatory without ,my ass~stivedevice or physical

.;

assistance during their initial clinical evaluation. Each lbject was either called at home
or approached while already visiting PADRECC for a prL-viouslyscheduled appointment.
Subjects or caretakers were presented with the purposc of the balance study as well as
what would be expected of the subject before, during cnd after testing along with any
risks involved. Interested participants were scheduled t:-, come in for testing and given a
study card with the date, time and location of the testing as well as contact information of
the author.

3.1. test in^ Location and Protocol.
The Hunter Holmes McGuire Veterans Affairs M zdical Center in Richmond,
Virginia, is one of six Veterans Health System centers of excellence for the treatment of
16

PD. Patients referred to the Parkinson's Disease Research, Education, and Clinical
Center (PADRECC) at this facility underwent a comprehensive interdisciplinary
evaluation that included examinations by a neurologist, nenropsychologist, trained

,P -> *
8'

!

j

movement disorders nurse, and physiatrist. Eligible particilpnts were evaluated by
PADRECC clinicians between September, 2004 and Aug~!,;?,
2005. The only ambulatory
subjects excluded from participation were those ascertained to be cognitively impaired to
the point of being unable to understand procedural instruct ion and safely ccinplete the
*

I

testing protocol. Demographic data was collected fiom pziients' medical records, clinical
'

interviews, and a directed physical examination. A signed consent form, consistent with
I\

Internal Review Board processes, was obtained, [APPENI'drX Cj.
<

*i:

3.2. Subiect Examination.
1

The examination of each subject began by presentiiag each subject with a consent
form consistent with Internal Review Board (IRB). The purpose and procedure of the
study as well as what would be expected of the subject during testing and any risks
involved were reiterated. The consent form was then signed.
An objective evaluation of the subject's balance was then taken to determine
motor functioning, stage of disease, and daily living skills. The instruments used were the
UPDRS motor section (UPDRS-111) and the BBS. These scales are described in detail in
sections 1.2.1 and 1.2.2, [APPENDIX A and APPENDIX B,respectively].
If PADRECC did not already have scores from the subject dated within three
months of the date of testing, they were obtained during the examination. The author

IS
performed the BBS and requested the service of a trained clinician to obtain the UPDRS

score.

3.3. Subject Testing Preparation Protocol.
,.

The demographic data of each subject including the subject's age and height were

enttred into the Srnhrt Balance aster@ (SBM) system computer. Name and the last four
digits of the social security number were also recorded irtro the system for future
reference. Subjects were asked to remove socks and shacs. Height was measured by
asking the patient to stand with hisher back to a wall where a measurement device is
located.
A common physical constraint of PD is a slouch o f the biick. The height of the

subject with slouch was measured. This slouch does affect the placement of the center of
gravity of the subject, moving it forward. This may have some affect on the validness of
using a COG calculation as opposed to using center of pressure calculation.
.

The patient was then fitted with a safety hamess, (Figure 7 ) , which connects two

suspension straps extending down fiom an overhead bar. The hiimess and suspension
system are used to help prevent falls if the patient loses balance. Three harnesses were
provided with the SBM system; small (S), medium (M) and large (L). Harness size was
determined based on the subject's height and girth. The harnes~was fitted to be
comfortable, but snug.

Gold D Ring

---

.Shoulder Strap '
Plastic Connector

Figure 7. Safety harness front (A) and back @).

The subject was then assisted into the SBM, stepping onto the forceplate. The
subject faced the visual surround during testing. As soon as the subject was inside the
SBM, the safety harness was attached to the suspension straps, (Figure 1). The straps
were then adjusted to allow for subject movement fiom side to side, but could still safely
break a fall, should the subject lose balance.
The subject's feet were then positioned on the forceplate by the author, (Figure 8).
The medial malleolus of each foot was centered directly over a thick line on the dual
forceplate positioned perpendicular to the subject. The lateral calcaneus was positioned
according to the subject's height. The forceplate is marked with lines named 'S', 'M'

and 'T' where
S = Short 30-55 inchesl76-140 cm
M = Medium 56-65 inched141-165 cm
T = Tall 66-80 inches1166-203 cm

Figure 8. Subject's feet positioned on forceplate.

Once the patient was properly positioned and comfortable, tests utilizing the SBM

may begin.

3.4. Subiect Testine; with the Smart Balance Master.

Testing involved examination and data collection, with a time span of
approximately forty-five minutes to one hour, depending on the subject. Before testing
began, each subject 'was informed that breaks would be permitted as needed during
testing. Subjects were also reminded of the restraining harness designed to provide

support and prevent a fall in the chance the subject did lose balance. Subjects were
advised to stand as relaxed and ail1 as possible during each test, and to stand as close to
vertical as possible. The system was then prepped by the author for the first test.
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Three CDP assessment tests were used to analyze the balance capabilities of the
ecta; the Sensory Organization Test (SOT), the Adapiaiion Test (ADT), and the
tjrnits of Stability Test (1,OS). " These three tests are desc! ibed in detail be.ic;w.
(./
r

'

9

3.4.1. Tbe Sensorv Organization Test (SOT).
i

'!
'VL$

The SOT is designed to assess a patient's use of 11: three sensory sjrstems that
F

i,

'cbntribuk to balance and identify any abnormalities in tkdI systen!s. The? . three
i

I

:

sknsory systems are the somatosensory system, visual s y ~ x mand vestibc:,:r system.
.C
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SO; protocol is comprised of six conditions in whici, the somatosensrry and visual

4
8$vironr@ents are systematically altered, as described in 2 able 3, (Figure 9 1 . The
phtient's responses to these environmental changes are m;.isured and recorded. The
environirrent is altered by systematically eliminating infornlation normally delivered to
the patient's eyes, feet and joints. The SBM handbook refers to this technique as
calibrated "sway-referencing. " " Sway-referencing allovr~the forceplate :tnd/or visual
surround to tilt, following the patient's anteroposterior bcdy sway. Sway-referencing,
corr~binedwith asking the patient to either open or close the eyes creates sensory
conflict situations for the subject and isolates vestibular halance contro)l, as well as the
adaptive. responses of the central nervous system.

Sensory Organizatbn Teat

Figure 9. The 6 sensory conditions of SOT protocol. (Courtesy of ~euro~om@'International,
hc.)
Table 3. Description of the six SOT tasks.

SOT Tasks
Condition 1
Condition 2
Condition 3
Condition 4
Condition 5
Condition 6

Condition Description
Eyes open, surround and platform stable
Eyes closed, surround and platform stable
Eyes open, sway-referenced surround
Eyes open, sway-referenced platform
Eyes closed, sway-referenced platform
yes open, sway-referenced -mound and platform, measured
over three trials each

A printout of this assessment was produced by the computer, [APPENDIX Dl.
The SOT Comprehensive Report provides four types of analysis: equilibrium score,
sensory analysis, strategy analysis and center of gravity alignment.
The equilibrium score quantifies the Center of Gravity (COG) sway or postural
stability under each of the three trials for each of the six sensory conditions. The
composite equilibrium score is the weight4 average of the scored of all sensory
conditions. It is designed to measure the overall level of performance.

The sensory analysis ratios are used in combinatiotl with the equilibrium score
* 1-

to identify specific impairments of the individual's sensory system. The four ratios
calculated are: Somatosensory (SOM), Visual (VIS), Vestibular (VEST) and
,f

~refereitial(PREF) , (Equations 7- 10).
Condition2
~ornato~ensory~atio
=
Conditionl
"

VisualRdtio =
z

Condition4
Condition1

Condition5
~ e s t i b u l i r ~ a t=
io
Conditionl

Equation 7.

Equation 8.

Equation 9.

Equation 10.

,

i
3 ,I.

;
-.
:

&rategy analysis and center of gravity (COG) alignment are also cslculated by the

fsystem,but were not used as analysis techniques for this study. Strategy analysis
alculates the relative movement of the body about the ankle and hips. These are
I'

commonly referred to as ankle strategy and hip strategy, respectively. Healthy
<S."

individuals primarily move about the ankle joints on a stable surface, and move about the
hip joints when the surface comes unstable. COG alignment measures the subject's
position on the forceplate at the start of each SOT trial.
The SOT is designed to measure how a subject organizes sensory information.
An inability to properly organize sensory information can result in balance instabilities
when the environment is shifted. This can include diminished visual clues (darkness,
lack of contrastldepth cues), unstable surface (sand, gravel, boat dock), or conflicting
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visual stimuli (being in a crowded shopping mall, watching a moving bus.) The SOT
attempts to determine if the subject is appropriately able t.n organize sensory information.

3.4.2. The Adaptation Test (ADT).

The Adaptation Test (ADT) consists of two different conditions (toes-up, toesdown) with five trials of each condition, (Figure 10). The QDT assesses a patient's ability
to minimize sway when exposed to surface irregularities .-nd unexpected changes in
support surface inclination. Sequences of platform rotati~rsin the toes-up or toes-down
direction elicit automatic motor responses. For each platk-nn rotation trial, a sway energy
score quantifies the magnitude of the force response req1:ired to overcome induced
postural instability. Unanticipated toes-up or toes-down rstations elicit automatic
responses, which tend to destabilize the patient's balance.
During the first (unexpected) trials, the initial distuptive responses are corrected
by secondary responses in the opposing muscles. With each subsequent trial, initial
reactions are attenuated and secondaryresponses strengthened to reduce overall sway.
Performance on the ADT requires adequate ankle range of motion and muscle strength,
as well as effective motor adaptation. The last of the five trials was utilized per the
standard SBM protocol. " Here it is assumed that as each trial progresses, the subject
learns what to expect and the energy score improves. A good performance score on the
ADT requires adequate ankle range of motion and muscle strength, as well as effective
motor adaptation.

Tom Up and Toes Down Rotations

Figure 10. Toes up and toes down rotations. (Courtesy of~ e u r o ~ o mInternational,
@
Inc.)

For each platform rotation trial, a sway energy score, (Equation 1I), quantifies the
magnitude of the force response required to overcome induced postural instability.
Equation 11.
1
0.025
Where the constants C1 and C2 are defined as C1= -and C 2 = - .
in/=
sec2
A printout of this assessment is then produced by the computer, [APPENDIX El.

The average, raw sway and center of force data for all five trials is also provided,
however this data was not used during analysis of the study.
The ADT attempts to determine if the subject is appropriately able to suppress
inappropriate automatic reactions, as well as ankle joint weakness and restricted range of
motion.

3.4.3. The Limits of Stability Test (LOS).
The Limits of Stability (LOS) quantifies the maximum distance a person can
intentionally displace their center of gravity (COG), i.e. lean their body in a given
direction without losing balance, stepping, or reaching for assistance. For each of eight
trials, the patient maintains their COG over the base of support as indicated by a cursor
display of the COG position relative to a center target, (Figure 11). On command, the
patient moves the COG cursor as quickly and accurately as possible towards a second
target located on the LOS perimeter (100% of theoretical limits of stability) and then
holds the position as close to the target as possible. The patient is allowed up to 8 seconds
to complete each trial.

Figure 11. LOS screen.

Based on the eight trials of the LOS test, five parameters are calculated: reaction
time (RT), movement velocity (MVL), endpoint excursion (EPE), maximum excursion,
and directional control (DCL). A printout of this assessment is then produced by the
computer, [APPENDIX F].
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The RT is measured i n seconds and is the time between the command io move
given by the system operator and the patient's first move. The MVL is measured in
, $1

degrees per second and is the average speed of the COG movement. The EPF is

.;;

I

expressed as a percentage. It is the distance of the first nlovement made by tl::-: subject
Ct!

.)

towards the designated target. The MXE is expressed as a percentage and is ~ h ~ e
8

*,

.:

maximum distance achieved during each trial. The DCL is expressed as a percentage. It
'ti*

&omparesthe amount of movement ili the intended direction (towards the designated
>

,i

target) to the amount of extraneous movement (away fiom the target.) The 1-0s test
a:

L

attempts to determine if the subject is voluntarily able to move hislher COG 1 tr positions
II

within the LOS.

'3.5. Completion of Subject Testing.

At the completion of testing cn the Smart Balanie

aster' system, the patient

was released fi-om the safety straps and asked to slowly i.m around, rotating 1.80". Once
the subject was facing the operator, the operator removed the safety vest and assisted the
subject with stepping down from the system. The subject then sat down and put socks
and shoes back on., The results of the test were printed and reviewed with the subject for
hisher information. The subject was then informed that testing was complete and was
walked out of the hospital.

CHAPTER 4: DATA ANALYSIS METHODS
1:

Data was analyzed with SPSS~,version 11.O, for Windows and Miixosoft Tixcel,
version 9.0.0.3822 for Windows. Means and standard deviations (SDs) f~: each . h f the
CDP measured were computed for the PD population and compared lo thos., of a healthy
population.

4.1. Data Variables.
All demographic data (age), scale measurement data (UPDM-S, BBS) and Smart
Balance Master@ data (SOT, ADT, and LOS test scores) were tabulated 111to an Excel
sheet, [APPENDIX GI. The name and last 4 digits of the subject's sgcial security
number were also recorded, but were not published.
Based on the parameters each test is designed to measure, SBM tests were divided
into two groups for statistical analysis. The first group, (Table 4) lists tests jn which the
PD subjects were expected to receive lower numerical scores when compared to the
healthy population data provided by ~ e u r o ~ oInternational.
rn~
All of the SOT scores, as
well as the LOS endpoint excursion, maximum excursion and directional coatrol measure
a percentage or a ratio. The LOS movement velocity measures how quickly the subject is
moving in degreeslsecond.

Table 4. Smart Balance Master tests the PD population is expected to score significantly lower in
when compared to a healthy population.
CDP Test
SOT Composite
SOT Somatosensory
SOT Visual
i
SOT Vestibular
SOT Preferential
LOS Movement Velocity
LOS Endpoint Excursion
LOS Maximum Excursion
LOS Directional Control

Units
ratio (%)
ratio (%)
ratio (%)
ratio (%)
ratio (%)
degreestsecond
ratio (%)
ratio (%)
ratio (%)
*.

The second group, (Table 5) lists tests in which the PD subjects were expected to
receive higher numerical scores when compared to the healthy population data provided
by ~ e u r o ~ o International.
m~)
The ADT test produces a number score measuring the
magnitude of force a subject is required to exert onto the forceplate in order to maintain
balance. The smaller the force required to prevent a fall, the 'better' the score. LOS
reaction time is measured in seconds and is the other test in which the lower the number
the subject receives, the 'better' the score.
Table 5. Smart Balance Master tests the PD population is expected to score significantly higher
in when compared to a healthy population.
CDP Test
ADT Toes Up
ADT Toes Down
LOS Reaction Time

Units
energy sway
energy sway
seconds

4.2. Adjusting the ~ e u r o ~ o m " ~ e a 1Population
thy
Data.
Healthy subjects were not tested by the author for this study. Healthy population
scores on the SBM system were provided in the appendix of the ~ e u r o ~ o International,
d*
Inc operator's manual. " However, the raw data from was unavailable. Only healthy

population means and standard deviations, divided by age groups 60-69, and 70-79,
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[APPENDIX HI, were available fiom the ~ e u r o ~ o mInternational,
""
Inc for statistical
analyses. Calculations were performed to combine these two subpopulations into a single
control group with an age range of 60-79 years (Equations 6-9).
The only other demographic information known regarding this data was the
breakdown by gender. In the age group 60-69, there were 12 males and 14 females. !n
the age group 70-79 there were 15 males and 14 females.

Equation !' .

Where, ?. : mean of the ~ e u r o ~ ohealthy
m
population, age range 60-69
m, : NeuroCom healthy population size, age range 60-69
-

: mean of the NeuroCom healthy population, age range 70-79
mb: NeuroCom healthy population size, age range 70-79
Yb

Equation

.7

Rearrange Equation 7:
-

Z(Y,
-Y)

2

=s:(m-l)=s:(m,

-l)+s:(mb -1)

Equation 8.

Where, s, : standard deviation of the NeuroCom healthy population, age range 60-69
sb: standard deviation of the NeuroCom healthy population, age range 70-79

Equation 9.

The newly calculated m,

k , and S,

[APPENDIX I] were then used to compare

the performance of patients with PD to that of normal subjects of a similar age. A sample
calculation is included in Appendix K.

4.3. Data Population characteristics.
Before any statistical. test can be performed on the acquired data sets, there are
two characteristics, which were described:
1) Are the data sets from each population of a normal distribution?

2) Are the comparing data sets of equal variances?
'

4.3.1. Determining Normal Distribution of Population Data
~ e u r o ~ o m~nternatiogal,
')
Inc has stated the published collection of data for a

healthy population
reflects a normal distribution. 7 1
..
Outliers were defined in this study as any value greater or less than 3-standard
deviation from the norm. Specifically, this rule applied to subjects deemed unmeasurable by the SBM system, as a result of recurring falls during testing. This
assumption was made based on observation that falls during testing were not determined
to be a normal occurrence in the PD population. Therefore, any subject's test with
recurring'falls, resulting in a score of zero on a SOT or LOS test or a score of 200 on the
ADT test was removed from the population before data analysis. With removal of these
outliers, this lowered the size of the PD study group depending on the specific tests from
45-5 1 subjects.
Data distribution for both the UPDRS and BBS scores as well as the twelve CDP
measurement scores of the PD population was characterized by referring to a
combination of skewness and kurtosis values, (Table 6) as well as histogram and P-P
plots, [APPENDIX J]. All visual representations were calculated and developed utilizing
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SPSS software. Skewness ahd kurtosis calculations were perfornred utilizing Micros,:.;ft

Excel. Calculated skewness and kurtosis statistics, (Equations 10 and 1I), showed al;
data sets to have a normal distribulion, (a=0.05). Further observation of data set
histograms and P-P plots appeared to agree with these findings. A sample calculatior. is
included in Appendix K.
Skewness Value = TestStatistic f 1.96 x S tan dardDeviation

Equation :3.

Kurtosis Value = TestStatistic k 1.96 x S tan dardDeviation

Equation I .

Table 6. Skewness and Kurtosis Tests: Normal Distribution Results.
Distribution?

.

Distribi:imn?

4.3.2. F-Test: Equal Variance Test.

Equal variance between population data sets was determined by calculating the Fstatistic, (Equation 12).
Equation 12.
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Where S 1 = sample variance of the PD Population and S2 = sample variance of the
healthy population. A sample dalculation is included in Appendix K. The populations
were found to have unequal variances for each of the twelve CDP measurements,
excluding ADT Toes Down, LOS Endpoint Excursion, L t3S Maximum Excursion and
LOS Directional Control, (Table 7). The critical F-value was found using a Student's tdistribution table. 24
Table 7. F-Test: Unequal Variance Results.
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4.4. T-Test :.Significantly Di ffei'ent Population Means Test,

Once the data sets were found to have a normal distribution, the twelve CDP test
score means of the PD population were compared to the twelve test score means of a
population without PD, provided by the NeuroCom* International, Inc. As the
comparative populations have unequal sample sizes and unequal sample variances (Ftest, a=0.05), a one-tailed Student's t-test (P<0.05) for independent samples was used
(equation 1I).

The t-distribution test is the tool used to measure the degree of significant
difference between the mean test scores 76 of the PD population (N=5 1) and the
NeuroCom healthy population (N=55).
i

Studies have shown the validity of the unpaired t-test is not severely coinprom: :d

by assuming equal variance, when they are not actually equal, as long as the populati;
sizes are equal. 48 However, when population sizes are not equal (for this study, the
population size varies) and sample variances are pet always equal, the accura~,of thc
test ratio can be affected. Therefore, the t-test ratio is modified so that it is no longer
based on a pooled variance estimate, but is based on the separate variances of the two
populations, (Equation 11).
..

Equation l i

Where,

X : mean of the PD population
S, : standard deviation of the PD population
n
: PD population size
Y : mean of the NeuroCom healthy population
S , : standard deviation of the NeuroCorn healthy population
m : NeuroCom healthy population size
The degrees of freedom were also adjusted, modifying the critical t-value,

(Equation 12). The critical t-value was found using a Student's t-distribution table. 2f

Equation i 2.
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The t-test chosen is cfesigned only to compare twc separate sample population
means. Tests of significant difference were 1-tailed with (.I= 0.05. A sample calculation
is included in Appendix K.
, ,.

.4

4.4.1. P-Value Test.

.for

The p-values were calculated to determine the probability that the PD sample
.

population tested couldshavebeen drawn from the worldwide PD population. The pvalue is a statistical significance test representing the pr(Yb3bility of obtaining values of
the test statistics that are equal to or greater in magnitude than the observed test statistic.
The p-values were obtained from the Student's t-distributbn table. 24

4.5. Correlation Analvsis.
A correlation analysis was performed, to determine which CDP measurements
held a strong correlation when compared to UPDRS and BBS scores. Pearson's Product
Moment Correlation (Pearson's correlation) was perfomled utilizing SPSS statistical
r
between two
software. Pearson's correlation reflects the degree of l i n e ~relationship
variables ranging from +I to - 1. A correlation of +1 means that there is a perfect positive
linear relationship between vayiables. The analysis was two-tailed, with a population size
of 48. Three subjects were not included in the correlation portion of the analysis because
their UPDRS and BBS scores were not available.

CHAPTER 5 : RESULTS

5.1. Demographic Data
Participants were 49 male patients and 2 female patients a! t~lePADREZC c l ~IC.
The average age of patients at study initiation was 72.18

+ 6.98 ycc-:s [range: 59-82]:

(Table 7).
' ,.

5.2. Clinical Data
.subjects vus 16. - i $_

The average score on the UPDRS motor examination for

6.77 [range: 7-33], (Table 8). The average BBS score for all subjt ts was 45.85

+ 6.

1

[range: 3 1-55], (Table 8).
Table 8. Demographic and clinical variables of study suls,l:cts (N=5 1)
p.

Variables
Age (years)
UPDRS
BBS

Mean + SD
72.18 6.98
16.75 6.77

+
+
45.85 + 6.41

....
**

--

Range
59 - 82
7 - 33
31 -53

.-

-

5.3. Comparative Population Means Data
The first group, (Table 4) was analyzed under the hypothes~sof the PD popul-ttion
scores measuring significantly lower when compared to a healthy population, (Tablc: 9).
They were tested with the null hypothesis:
- -

Ho: X > Y ; H a :

X<Y

Table 9. Significant difference-of Smart Balance Master test scores comparing PD population
(N =5 1) and NeuroCorn healthy population (N =5 5 ) , a = 0.05: Part 1.
-

SOT Camp
SOTSom
SOT Vis
SOTVest
SOT Pref
LOS MVL
LOS EPE
LOS MXE
LOS DCL

Healthy
Population
N,
Y
S,
51 75.09 5.651
50 96.49 6.091
50 88.76 5.845
51 69.24 9.804
49 96.98 11.27
50 3.736 1.374
50 70.42 12.14
50.!, 87.18 14.13
45 72.18 8.038

r-test

PD Population

CDP Test

1

X

S,

66.49
95.71
81.95
44.49
101.5
2.02
47.54
60.96
69.67

12.377
3.946
14.132
24.349
14.563
0.998
15.069
17.379
10.079

N,
55
55
55
55
55
55
55
55
55

-4.54
-0.79
-3.17
-6.77
1.753
-7.37
-8.51
-8.43
-1.35

P-value

dof

T0.05

p0.05

Reject
HO

58.8
93.4
64
54.8
90.1
'j8.4
94.1
94.6
33.3

-1.667
-1.661
-1.669
-1.669
1.662
-1.661
-1.601
-1.661
-1.663

< 0.0005

X

0.28
0.001
<0.0005
0.04
< 0.0005
< 0.0005
< 0.0005
0.08

X
X
X
X
X
X

t

The second group, (Table 5) was analyzed unde~tile hypothesis of PD population
scores measuring significantly higher when compared to ;z healthy population, (Table 10).
They were tested with the null hypothesis:
Ho: X < Y-.. $
Ha: X > Y "'

"I

>

r.

Table 10. Significant differencebbfSmart Balance Master test scores comparing PD population
(N =5 1) and NeuroCom healthy population (N =.55),
.... a = 0.05: Part 2.
PD Population

CDP Test

~9
s,
ADT Toes
UP (5th)

ADT Toes

DN (5th)
LOS RT

Healthy Population

N ,

Y

t-test

P-value

Sz

Nz

Tabs..-

dof

To.05

Po.05

66.35

21.69

48-2- 62.92

14.51

55

0.940

81.7

1.664

0.16

57.61

17.96

51

54.82

20.05

55

0.755

104

1.66

0.23

0.979

0.362

55

7.363

75.4

1.665

< 0.0005

-,,

Reject
Ho

'-

1.66

0.527
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All CDP measurements of the PD population, with the exception of SOT
k'

Somatosensory subscore (p=0.28), LOS Directional Control subscore (p=0.08), ADT
Toes Up 5th(p=0.16), and ADT Toes Down (p=0.23), were significantly different in
comparison to the healthy population at a level of a=0.05.

X

5.4. Correlational Data
Correlation analysis utilizing Pearson's p found that not all of the CDP
measurements arc indicative of what the UPDRS cr BBS are designzd to measiire,.(?';,'.)le
11). The correlation analysis was used to determine which CDP subscores are most
appropriate to use when determining PD postural instabilities.
A strong positive correlation was found between the BBS and SOT Composite,
SOT Visual, SOT Vestibular, LOS Movement Veiocity, LOS Encipoint Excuj: :on, L.. 3

~ a x i m u mExcursion and LOS Directional Control subscores. A p,,sitive corrt:latiofi
indicates that as the BBS score decreases (measures more postural ~nstability)r'ne CTi
subscores also decrease. A strong negative correlation (a=0.01) 15 d!; found be~weenI!. :
BBS and ADT Toes Down (5thtrial) subscore and Age. A strong ricgative correlatio~
was also found between the UPDRS and SOT Composite and SOT Vestibular subsco, cs.

'A moderate
negative correlation (a=0.05) was found between the VPDRS and LOS
Maximum Excursion subscore. A negative correlation indiwees that as the BDS scort
decreases (measures more postural instability) the CDP subscores GS well as age incrr- kse.
Table 11. Pearson's p correlation of CDP measurements to UPDRS and BBS scores.
CDP Tests
SOT Camp
SOT SO^
SOT Vis
SOT Vest
SOT Pref
ADT Toes Up 5th
ADT Toes Down 5th
LOS RT
LOS MVL
LOS EPE
LOS MXE
LOS DCL
Age

UPDRS (r value)
-0.428
-0.015
-0.224
-0.474
-0.006
0.125
0.118
0.086
-0.22
-0.23
-0.311
-0.101
0.116

Significance

**

**

*

BBS (r value)
0.501
0.089
0.478
0.443
0.059
-0.21
-0.37
-0.05
0.399
0.552
0.562
0.4
-0.43

**
**
**
**
**
**
**
**
**

2.

-3.

Significalt e

:if

CHAPTER 6: DISCUSSI~:)N
6.1. Describing the Balance Deficits of the PD Patient.
This study demonstrates that there were significaril differences measured by CDP,
0
using the Smart Balance aster@ system, when comparing a PD population to an age<

matched healthy population. While these abnormalities of postural instability were
.I
p
expected given the nature of PD, the specific areas of normal balance hnctioning in this
* - r ,

, ;7>

patient population was not anticipated. The specific aspects of postural instability
I &

identified by the SOT, LOS and ADT tests and their resp,.ctive subscales may point to
I

either the selective neurologic deficits associated with PD or the effect of varying
severity of PD in this investigation. It is important to note, the nature of this study utilized
only relatively high-functioning PWP who could fully pariicipate in the testing
procedures. This requirement limited the generalizability of these results to those with
early or mild PD.

ir,

6.1.1. The Sensorv Organization Test (SOT).
The Sensory Organization Test provides five measurements or subscales whost
3 . .

values can provide insight to the clinician as to which sensory systr.~n(s)may bt.
contributing to instability, as well as a more detailed treatment appro~ch.The 1 iean
Composite subscore of the PD population was significantly lower t\l,in that of n nealtk
population. This subscore represents an overall performance level of the patiel-,!. A
lower score b-ggests the PD popukiti~iiwas c n a h ! ~to maiiitain baiancr 2nd a sl.ible
position during the SOT test procedure. The lower score may impl). the overall balan
deficit of the PWP is related to an off balance center of gravity, hip or ankle dc ~ i n a n
strategy analysis or abnormal sensory scores. The mean Visual and v'estibular :.ubsc: ,s
of the PD population were both significantly lower than those of a Ilcalthy p o latior:
~ ~
These subscores are designed to indicate how well the patient utilirses their vis!:.il and
vedibular systems, respectively. The mean Preferential Visual sub?c:ore of the I'D
population was hypothesized to be significantly lower than that of a healthy pccrulatic
However, analysis revealed the mean subscore to be significantly greater in corxiparis

4

to a healthy population, suggesting a PWP will use the visual syste~nmore thar: other
sensory systems when compared to a healthy population. These findings are
counterintuitive, given the increased prevalence of visual scanning difficulties seen wi'h
PD. Further investigation into this observation is warranted. The mean Somatosensoq,
subscore of the PD population was not significantly lower than that of a healthy
population. This finding suggests that when working to maintain balance, the PD
population utilized the somatosensory system to the same degree that a healthy
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.,:

population does. Therefore the Somatosensory subscore di3es not appear to be a useful
tool for evaluating the postural instabilities specific to a PD patient.
>

I .9 .

3 . t

6.1.2. The Adaptation Test (ADTI.
:

The Adaptation Test provides measurements used :o describe a patient's ability to
.

stabilize balance using d.minimum force when successiveiy shifted off balance. The
mean ADT Toes Up 5thsubscare and ADT Toes Down 5"' subscore of the PD populatiom!
were not significantly geater than that of a healthy population. This finding suggests
that when successively shiftedbfonvard or backward and c!ff balance, the PD patient does
not supply asignificantly greater force to maintain balanc.: in comparison to a patient
without PD.:

!

6.1.3. The Limits of Stability Test (LOS).
The Limits of Stability test provided five measurements used to describe the
-subject's

mobility and range of motion, and can be used to quantify the current abilities
I

of the patient. Our findings support the theory that the Smart Balance

aster' system

has the capability to accurately quantify balance deficits specific to PD as seen during
cue-induced motion. The mean Reaction Time subscore of the PD population was
significantly higher than that of a healthy population. This subscore quantified the degree
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this response time has slowed and supports the observation that a PD patient

'aften take longer to respond to a motion cue. The mean Movement Velocity subscorc; f
the PD population was significantly lower than that of a healthy population. Titis
subscore quantified the velocity of a PWP once mction beings and supports the
observation of a slower motion. Following that sarne concept of a slower velocity, thl
mean Endpoint Excursion and Maximum Excursion subscores of the PD population v. .re
i

1

also significantly lower than that of a healthy population. This supported the ctjserva! )n
,'t

of 21 PWP ;;.ilI not shifting their weight as far as a patient without PD. Further, a lowe
1

MXE subscore suggested the PWP, even if they sie able to shift their weight (e.g., p,,
majority of'weight on the right foot), may not be 8ible to maintain that new po>;tion fc4- an
extended period of time. The MXE subscore alsc, dllows the clinician to ignol- , over: lot
by a patielit who is able to weight shift, but not al~leto direct their position to 3 specif: :
target.

6.2. Interpreting Abnormal SBM Scores for a PD Pilajmt.

Once it has been determined a PD patient possesses a particular balance deficit, it
is vital the operator correctly interpret the meaning of the different test scores: and thvir
functional implications for a patient.

-

6.2.1. The Implications of an Abnormal SOT Score for a ?-I Patient.
.: t?

Patients with abnormal SOT scores usually experiei~cedifficulty with surface
irregularities or misunderstood visual cues (standing on a qtreet corner, watching a bus
drive by). These measurements, particularly the composite and vestibular ratios, can
<

prove valuable when attempting to quantify the particula~aalance deficits of each PD
..

patient.
2

:;I (

The SOT composite scdre, which takes into consicieration all six conditions, is
determined abnormal when itlfills below the 5thpercentill: of the correct age-matched
population. As a guideline, fopla patient to be considered as possessing normal postural
stability, thecomposite Qcoredrist be normal.

6.2.2. The Implications of an Abnormal ADT Score for a_"

Patient.

Patients with abnormal ADT scores will usually experience difficulty with surface
irregularities (gravel) or changes in inclination (tripping). PD patients are ofien unable to
suppress inappropriate 'autom&+icreactions. PD patients are often characterized by their
diminished ankle strategy. One current method of determining the ankle strategy of a
patient is part of the UPDRS-111. During this retropulsiori test the patient is asked to face
away from the clinician. The clinician braces behind the patient, grasps the patient's
shoulders and pulls the patient towards the clinician. Retropulsion is described as how
many steps the patient requires before regaining balance. A patient without a balance

deficit would not require any steps and would be able to use &re strategy to regain
balance. PD patients sometimes require 2-4 steps before regaining balance, or must be

.

caught by the clinician.
,

The ADT test provides a very appropriate and safc nrzthou of discerning and e s m

quantifying the ankle strategy of a patient.

*,A

6.2.3. The lmpli~a~ons-of
an Abnormal LOS Score for a PD Patientli.
<

Patients with abnormal LOS subscores will usually experience difficulty with
weight shifting activities such as taking an object off a shelf or climbing in and out of a
bathtub. P3tients with a fear a falling may show even lower subscores as they may bc
unwilling to lean as far as they actually are capable of doing. PD patients who have a
history of falls may present this in their Endpoint Excursion and M.aximum.Excursion
scores. The EPE and MXE may also prove to be another valuable rluantification of arikle
strategy. PD patients often move at a slower speed, something quantified by the . Movement Velocity score. The Reaction Time of the PD population also proved to be an
indicator of a patient's ability to shift weight.

6.3. Correlation between the SBM subscores and UPDRZ-2nd BBS scores.
A majority of the Smart Balance Master subscore2 hold a strong positive or
negative correlation (a=0.01) to the BBS. This may be dl;.: to the design of the BBS,
which is intended to specificallymeasure postural instabill ty. UPDRS, however,
measures the overall motor control of the PD patient, incit ding facial expression, finger
taps and tremor as examples.
I would like to propose a future look into the ratio:: provided by the SBM for the

.- ,

SOT and LOS tests. In retrospect, it might have been mniz valuable to correlate the raw
data from each of the six conditions between the two populations, as opposed to
correlating the calculated ratias computed by the system. This type of analysis would
require testing a minimum of 3.0 subjects with no known r:eurological disorders,
dementia, or balance deficit. I.propose 30 subjects because this number defines a large
population. However, after 5-10 subjects are test, a powev test should be performed to
determine exactly how many subjects are required to test.
While the ratios calculated by the SBM provide vtiluable insight into the varying
<

postural instability of each PD patient, raw measurements might show a stronger
correlation to the findings of the UPDRS or BBS.
Further a breakdown of the UPDRS or BBS scale?;might also show a stronger
correlation. Because different parts of the scales measure different aspects of postural
instability, it might prove more meaningful to correlate matching numbers. For example,
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;the measurements of the ~ 0 T t e smight
t
be compared to numbers 6,'?,8 and 9 scores in

the BBS, [APPENDIX B]. The measurements of the ADT test mi;$tt be compared to the
'Postural Instability' score in the UPDRS, [APPENDIX A].
I.,.,

.I,

6.4. Addressing the Design Specifications of NeusoCom's SBM Syztem,
The data collection and analysis performed in this study pr.;:,tnt the SBM systr n
L

as a clinical tool, which can be used to measure the postural instaklkry of a patient. A
:
';

deeper look will now be taken into the overall reliability of the sys:::m when used on i.\e
Parkinson's disease population.

.:
6.4.1.
The Testing Protocol of the Smart Balance ihllaster system.
-

The PD population contains a number of r,,:rsons constraic,:~to abnormal foot
positioning. Of concern is the requirement by thc SBM system to p:)sition the feet pri )r
to testing. During data collection for this study, subjects with abnu-ma1foot position~rlg
were increasing uncomfortable and unstable during testing. This suggests the data
collected was not solely a function of PD, but also abnormal foot placement something
this study was not designed to test. The SBM tests were not a mec?sureof the subject'.;
day to day balance requirements, but were instead a measure of thc subject's postural
instability as a result of PD and a new foot position. In general, the foot positioning
requirements did not seem to have an effect on the slighter positioning issues of subject

47
with for example a regular "duck foot" stance. It did affect subjects with an exasperated

"duck foot" stance,.md
-. those who stood with toes pointing inwasti
A suggestion to correct this foot placement requirement is :n base all SBM
measurements and calculations on the present position of tile fool iag prior to testing,

.

instead of requiring subjects to fit a designed mold. This ~z,ouldr:iluire a system that can
identify the foot placement of the subject, and then calcula!e the lilcation of the center of
mass of the subject based on hisher individualized foot pl;)cemert.
. ..
*

1

..
r,,bL

6.4.2. The Implications of Instrument Filter Use on PD S~l'kectRI-sponseTime.
I I.'[

A person affected with ~arkinslk'sdisease (PWP~I:xhibili a slowed reaction time
and motor response. NeuroCom's use of a second-order i dttenvi4.thfilter in the SBM
biofeedback system implies any processed signal ~xportet.~
jack tc the subject is no longer
a real time signal. The problem with this is this signal is :;-lselyp-esented as real time to
the batient, as well as the clinical opentor. What

I.;

the e- :ct of a non-real time

1.

biofeedback signal being presented as ;I real time :;ignal c ~ l a PWT subject's response
'L

time? A response time, which has already slowed due to r;ie dise:lse?
/

If this delayed response time can be determined te ,'urther affect the response of

the'^^^ subject, t h 2 ~ m a rBalance
t
Master is no ionger tr$easuritigthe pure unaffected
movements of PWP subject. The only way to remedy this delay titne issue is to use
instrumentation so precise that no filtering system is necessary. 'I'he resulting signal may
have aliases, but there is an opportunity to adjust for these withoiii further distressing an
already inhibited PWP reaction time.
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APPENDIX A
The UNIFIED PARKINSON'S DISEASE RATING SCALE: PART 3
MOTOR EXAMINATION (UPDRS-111)
Speech

O=Normal
l=Slight loss of expression, diction and/or volume
2=Monotone, slurred but understandable; moderately impaired
3=Marked impairment
4=Unintelligible

Facial Expression

O=Normal
l=Minimal hypomimia, could be normal "poker face"
2=Slight but definitely abnormal diminution of facial expression
3=moderate hypomimia; lips parted some of the time
4=Masked or fixed facies with severe or complete loss of facial expression; lips
parted % inch or more

Tremor at Rest
RUE
LUE
RLE
LLE
Head

O=Absent
l=Slight and infrequently present
2=Mild in amplitude and persistent or moderate in amplitude, only
present intermittently
3=Moderate in amplitude and present most of the time
4=Marked in amplitude and present most of the time

Action or Postural
Tremor of Hands
R
L

O=Absent
l=Slight; present with action
2=Moderate in amplitude; present with action
3=Moderate in amplitude, with posture holding as well as action
4=Marked in amplitude, interferes with feeding

Rigidity
RUE
LUE
RLE
LLE
Head

O=Absent
l=Slight or detectable only when activated by mirror or other
movements
2=Mild or moderate
3=Marked, but full range of motion easily achieved
4=Severe, range of motion achieved with difficulty

Finger Taps
R
L

O=Normal
l=Mild slowing andloir reduction in amplitude
2=Moderately impaired. Definite and early fatiguing. May have occasional
arrests in movement.
3=Severely impaired. Frequent hesitation in initiating movements or arrests in
ongoing movements
4=Can barely perform the task

Hand Movements
R
L

O=Normal
l=Mild slowing andlar reduction in ampl~tude
2=Moderately impaired. Definite and early fatigultlg. May have occasioilal
arrests in movement3=Severely impaired. Frequent hesitation in initianng movements
4=Can barely perform the task

Rapid Alternating
Movement of Hands
R

l=Mild slowing a n d m reduction in amplitude
2=Moderately impaired. Definite and early fatiguir~g.May have
occasional arrests i n movement.
3=Severely impaired. Frequent hesitation in initiating movements or arrests in
ongoing movements
4=Can barely perform the task

Leg Agility

l=Mild slowing andlor reduction in amplitude
2=Moderately impaired. Definite and early fatiguing. May have
occasional arrests isl movement.
3=Severely impaired. Frequent hesitation in initiating movements or arrests in
ongoing movements
4=Can barely perform the task

R

Arising From A
Chair

O=Normal
l=Slow; or may need more than one attempt
2=Pushes self up from arms of chair
3=Tends to fall back and may have to try more than once, but can get up without
help
4=Unable to arise without help

Posture

O=Normal erect
l=Not quite erect, slightly stooped posture, could be normal for older person
2=Moderately stooped posture, definitely abnormal, can be slightly leaning to
one side
3=Severely stooped posture with kyphosis; can be moderately leaning to one
side

Gait

O=Normal
l=Walks slowly, may shuffle with short steps, no festination
2=Walks with difficuP;ty, requrres little to no assistance, may have some
festination, short steps or propulsion
3=Severe gait disturbance requiring assistance
4=Can not walk at all even with assistance

Postural Instability

O=Normal
l=Retropulsion, but recovers unaided
2=Absence of postural response; would fall if not cai~ghtby examiner
3=Very unstable, tends to lose balance spontaneously
4=Unable to stand without assistance

Body Bradykinesia

O=None
l=Minimal slowness, movements deliberate character, could be normal ior older
person
2=Mild degree of slowness and poverty of movemcr~twhich is definitely
abnormal. Some reduced amplitude
3=Moderate slowness, poverty or small amplitude cf movement
4=Marked slowness, poverty or small amplitude of luovement

Part 3 Score:

APPENDIX B

The Berg Balance Scale (RBS)

1. SITTING TO STANDING
INSTRUCTIONS: Please stand up. Try mot to use your hatrds for s! ;$port.
()4
()3
()2
() 1
()0

able to stand without using hands and stabilize independertly
able to stand independently using hands
able to stand using hands after several tries
needs minimal aid to stand or to stabilize
needs moderate or maximal assist to stand

2. STANDING UNSUPPORTED
INSTRUCTIONS: Please stand for 2 minrtes without holding.
()4
()3
()2
() 1
()0

able to stand safely for 2 minutes
able to stand 2 minutes without supervision
able to stand 30 seconds unsupported
needs several tries to stand 30 seconds unsupported
unable to stand 30 seconds unassisted

If Subject is able to stand 2 minutes unsupported, score full points fc sitting unsupportecl.
Proceed to item #4.

3. SITTING WITH BACK UNSUPPORTED BUT FEE C SUPPt JRTED ON FLOOR OR
ON A STOOL
INSTRUCTIONS: Please sit with arms fdded for 2 minutes.
()4
() 3
()2
() 1
()0

able to sit safely and securely for 2 minutes
able to sit 2 minutes under supervision
able to sit 30 seconds
able to sit 10 seconds
unable to sit without support 10 seconds

4. STANDING TO SITTING
INSTRUCTIONS: Please sit down.
()4
()3
()2
() 1
()0

sits safely with minimal use of hands
controls descent by using hands
uses back of legs against chair to control descent
sits independently but has uncontrolled descent
needs assistance to sit

5. TRANSFERS
INSTRUCTIONS: Arrange chair(s) for a pivot transfer. Ask subject to transfer one way
toward a seat with armrests and one way toward a seat without armrests. You may use 2 chairs
(one with and one without armrests) or a bed and a chair.
( ) 4 ,,tble to transfer safely with minor use of hands
( ) 3 able to transfer safely definite use of hands
( ) 2 able to transfer with verbal cuing andlor supervision
( ) 1 needs one person to assist
( ) 0 needs two people to assist or supervise to be safe

6 . STANDING UNSUPPORTED WITH EYES CLOSED
INSTRUCTIONS: Please close your eyes and stand still for 10 seconds.
()4
()3
()2
() 1
()0

able to stand 10 seconds safely
able to stand 10 seconds with supervision
able to stand 3 seconds
unable to keep eyes closed 3 seconds but stays steady
needs help to keep from falling

7. STANDING UNSUPPORTED WITH FEET TOGETHER
INS$RUCTIONS: Place your feet together and stand without holding.
( ) 4 able to place feet together independently and stand 1 minute safely
( ) 3 able to place feet together independently and stand for 1 minute with supervision
( ) 2 (able to place feet together independently but unable to hold for 30 seconds
( ) 1 needs help to attain position but able to stand 15 seconds feet together
( ) 0 needs help to attain position and unable to hold for 15 seconds
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8. FACING FORWARD WITH OUTSTRETCHED ARM WHISE STANDING
INSTRUCTIONS: Lift arm to 90 degrees- Stretch out your fingers and reach forward as far as
you can. (Examiner places a ruler at end mf fingertips when arm is at 90 degrees. Fingers should
not touch ruler while reaching forward. Tbe recorded measure is the distance forward that the
fingers reach while the subject is in the most forward lean position. When possible, ask subject
to use both arms when reaching td avoid retation of the trunk.)
()4
()3
() 2
() 1
()0

can reach forward confidently > 25 cm (10 inches)
can reach forward > 12 cm safely (5 inches)
can reach forward > 5 cm safely (2 incbes)
reaches forward but needs supervision
loses balance while tryinglrequires external support

9. PICK UP OBJECT FROM THE FLOOR FROM A STANDITGG POSITION
INSTRUCTIONS: Pick up the shoelslipper, which is placed in front of your feet.
()4
()3
()2
() 1
()0

able to pick up slipper safely and easily
able to pick up slipper but needs supervision
unable to pick up but reaches 2-5 cm (1-2 inches) from slipper and keeps balance independently
unable to pick up and needs supervision while trying
unable to trylneeds assist to keep from losing balance or falling

10. TURNING TO LOOK BEHIND OVER LEFT & RIGHT SHCWLDEKS WHILE
STANDING
INSTRUCTIONS: Turn to look directly behind you, over your left shoulder. Repeat to the
right.

,

()4
()3
()2
() 1
()0

looks behind from both sides and weigu shifts well
looks behind one side only, other side shows less weight shift
looks sideways only but maintains balamce
needs supervision when turning
needs assist to keep from losing balance or falling

11. TURN 360 DEGREES
INSTRUCTIONS: Turn completely a r o u d in a full circle. Pause. Then turn a full circle in the
other direction.
()4
()3
()2
() 1
()0

able to turn 360 degrees safely in 4 seconds or less
able to turn 360 degrees safely one side only in 4 seconds or less
able to turn 360 degrees safely, but slowly
needs close supervision or verbal cuing
needs assistance while turning
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12. PLACING ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING
UNSUPPORTED
INSTRUCTIONS: Place each foot alternately on the steplstool. continue until each foot has
touched the steplstool4 times.
()4
()3
()2
() 1
()0

able to stand independently and safely and complete 8 steps in 20 seconds
able to stand independently and complete 8 steps > 20 seconds
able to complete 4 steps without aid with supervision
able to complete > 2 steps needs minimal assist
needs assistance to keep from fallinglunable to try

13. STANDING UNSUPPORTED ONE FOOT INFRONT
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT) Place one foot directly in front of the
other: If you feel that you cannot place your foot directly in front, try to step far enough ahead
that the heel of your forward foot is ahead of the toes of the other foot. (To score 3 points, the
length of the step should exceed the length of the other foot and the width of the stance should
approximate the subject's normal stride width.)
()4
()3
()2
() 1
()0

able to place foot tandem independently and hold 30 seconds
able to place foot ahead of other independently and hold 30 seconds
able to take small step independently and hold 30 seconds
needs help to step but can hold 15 seconds
loses balance while stepping or standing

14. STANDING ON ONE LEG
INSTRUCTIONS: Stand on one leg as long as you can without holding.
()4
()3
()2
() 1
()0

able to lift leg independently and hold > 10 seconds
able to lift leg independently and hold 5-10 seconds
able to lift leg independently and hold = or > 3 seconds
tries to lift leg, unable to hold 3 seconds but remains standing independently
unable to try or needs assist to prevent fall
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consent and discontinue participation at m y time. tl P I M e to withdrrw hum
this study, you should contad Dr. Qutubuddin Dismnhuabnwin in no way affect
or jeopardize the quality of m e you recein a lh6 insnow a in tho Mum or
your right to participate in other studiifor which you w eSgrMe.

I

I

Your study dw3whay also r r i t h d m ymif you do not Mbwthe study doctor's
directions or if vudr medical cundiins ch;aPe.The stulv doctor. M u i r e IRE or
government r&ulatory agenctes, could dirc&nue the &re study at any h e ifthe
safelv of research sub~eclsis found to be & s i g n i i kk Ifthis studv r -Dad
for a& reash, you wiil be asked to go ihmrgha find examination to ciw%k y&ir
general health.
I

Any significant n m findings Llpat devebp during the mU!Se of the re-search study
that in the minion of the sludv d o c h maw affect
mllinaness b contiiua to
participate &W
be providedbo;ou as
as p o s b k

-

12. Who should Icontact kr erne-

*-w,
quas-?

I

(Contacts)

If you have ansr questions regarding
I
l
yreactions, a y w ah'
injured and became ill as a result of parb@lpatan intt*s SWy, please call (24 hours);

,.

.

Telephone Numbers:
Abu Qutubuddin. MD.
David C i i . MD.

23fI

am

- 4'Mpm

(w) (804) W!j-S331
(w)(804) 87-31

,

Audknm
(804) 351-7620
(804) 997-6468

If y w are unable to reach any d the health ere providers l i i and nee:
immediate medical assistance for a m s e h rebbad W f y please call the,VAW
hospital operator at 800-784-6381 and as* for the Emergency Room physmn s;
obtain advice. You may also call the
Rwm d i i at 8048755527. !f
you have any questions oonceming yous nghk as a research partidpant. p u ma,,
contad the McGuire Institutional Review B w r d (IRB) at 804-675-5876. The IRR
rvw
ing
i
research in muman subpctp and verifying that safe:,
responsible for e
integrity and human rights a# the subjects a ~ pmtecled.
e
13. Date of Consent Form Revision: damraw 25.2005
:tv,-:i;

.

;
,{,,3.m,3!

..*>*..
-;!tarudZ

-7T-~:c.j
G:>,.::ni,'i%'~.

,iCLto bn iigr.e::
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:

Patient Initmls -

i

Subject Name.

. ,

Date'-.--

T i of Study: The ure of Compate6z.d Poslumgnphy Testing to Asssu Emlance i;)lrrdividuab
with Parkinson's Disease
1.

VAMC: Rirhmrrl

Pnnclpal Invesbgatw:
3

RESEARCHSUBJECTS' RIGHR.1 have read a have had read to me sl Df the above.

l unewstandmat ldo m
t have to take part In this study, and my refusalto p k @ t e w i l ~ h v c kr

~

)

'

lossDfwMotowhlchlam~,~maymthdrawhm~rtudyatay~~utpend(y~bud~~~~
dhabemfilstowhlchlame~~The~ofLhk~maybe~,~myrecordr~mtbe
revealed unless requ~red
by law

l understand my rights as a mead%
subject. a
n
d
. l mdmc'(rrd
what thm sbwly is about ardhow and wl3y it is bekg done. IVMreceius a slgned and &ted mpy d m b r
consent fum.

I

'

Subjeci's Signature
Signature of Subject's Re.-

Print NanelDate

( Signature of Wmesr

'

." I
.,

II

Signaiure of P e n n ObtainingInfomad Msent

RintthwDate

signature of Investigator

I

*Only required if subject is not competent.

VA FORM 10-1086 IF MORE MAN ONE PAGE IS USED EACH
NUMBERED
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Pahent lnit~als

APPENDIX D

THE SENSORY ORGANIZATION TEST (SOT) PRINTOUT EXAMPLE

-

~ - 0 3 6 & # , , , &

mPdmn'IObrr
grcle;ucQdlk-E
- m r . * m )

MFDlmW
p $ l ( ; l l ~

142V45

Sensory Organization Test
l

~

~

a 1.0) h

Data Range Nom NeuoCom Data Ranga6 0 4 B
P a l T e Dan*le

.Wl*

r

APPENDIX E
THE ADAPTATION TEST PRINTOUT EXAMPLE

Adaptation Test

I

Data Range Not.:
MTMtConmt.

NuoCom DaIa Rmaw 60-40

APPENDIX F

THE LIMITS OF STABILITY TEST (1,OS) ! RINTOUT EXAMPLE

N . m r " w
E
!L-

Dateof Birth: 8ffiH935
Sk
Comments:

-

Parkinson's Diswrs
McGulh.Theresa E
Referral Soua: patisml'r retala1

.-

Limits Of Stability

I

RT

Translion

n

(sec)

MM
(deglsec)

EPE

MXE

DCl.

(%)

(%)

(%)

1

im LOS

1

Fils: FDllO.Dilr

DZ
tlIJOmW

n i i 14.39 21
-

5

deglsec Movement Velouly(MVL)
100
1
20
00
F
-

1

% EndpointBMax Excursions(EPESUIXE) X

8.d

w

L a

Data Range Note: NeuroCom Data Fawe: 60-69
Post Test Comment
I

I

c-

Directional Control(DCL)

NanoCm Sy~temVcnim8.20. C ~ 8 1 9 0 9 - 2 0 XNewoComQ In(crnama1 lhc An Rim-R

APPENDIX G
PARKINSON'S DISEASE POPULATiilN RAW DATA

APPENDIX H
NEUROCOM HEALTHY POPULATION MEANS AN'Q STANDARD
. DEVIATONS DVIDED BY AGE GROUFS

Table H.1. Sensory Organization Test NeuroCom Healthy Population Means and
Standard Deviations
Sensory Organization ~
(SOT)
Composite
Somatosensory
Visual
Vestibular
Preferential

e

z

Ages 60 - 69
Mean
SD
77.59
5.99
97.2
3.2
90.9
5
69.7
9.3
98.4
6.5

'

Ages 70 - 79
SD
Mean
72.85
5 -43
9j.l
7.9
ii5
6.6
67.3
10.4
14.4
94.9

Table H.2. Adaptation Test NeuroCom Healthy Population Mezns and Standard
Adaptation Test (ADT)
Toes Up (5thtrial)
Toes Down (5thtrial)

Ages 60 - 69
Mean
SD
59.56
14.10
49.13
15.87

.--.

Ages 70 - 79
SD
Mean
65.93
15-10
5r.93
23.46

Table H.3. Limits of Stability Test NeuroCom Healthy Population Means and Standard
Deviations
Limits of Stability (LOS)
Reaction Time (RT)
Movement velocity (MVL)
End Point Excursion (EPE)
Maximum Excursion (MXE)
Directional Control (DCL)

Ages 60 - 69
Mean
SD
0.9
0.36
4.0
1.1
72.0
9.1
87.6
9.6
70.7
7.9

Ages 70 - 79
Mean
SD
1 05
0.37
3.5
1.6
69.0
14.5
85.8
17.4
33.5
8.3

APPENDIX I
ADJUSTED NEUROCOM HEALTHY POPULA.TION MEAN Alc'D SD
a
DATA

APPENDIX J
HISTOGRAMS'& P-P PLOTS OF PD POPULATION

Normal P-P Pld of UPDRS

Observed Cum Prob

.

Figure J.1. @DRS Histogram & P-P Plot of PD Data.

mP-P Plot of BBS

O b ~ e ~ Cum
e d Prob

Figure 5.2. BBS Histogram & P-P Plot of PD Data.

Normal P-P Plot of SOT Composite

SOT CoqkMte

Crtrwed

~ U WPr0D

Figure 5.3. SOT Composite Histcygam. & P-B Piot of PD Data.

Normal P-P Plot of SOT Somatosem

SOT Somatosensory

Observed Cum Prob

Figure 5.4. SOT Somatosensory Histogram & P-P Plot oEPD Data.

Normal P-P Plot of SOT Visual

SOT Visual

Observed Cum Fmb

Figure J.5. SOT Visual Histogram & P-P Plot of PD Data.

Mrrnal P P Plot of SOT Vest~hhr

--

814. Dev = 24.35
Meon 44.5
N

...

SOT Vestibular

51.00

Observed Cum Rcb

Figure 5.6. SOT Vestibular Histogram & P-P Plot of PD Data.

:.-

96
NMmd P-P Plot of SOT Referential

Std Dev = 14 58
Mean = 101 5
N = 49 00
85 0

76 0

850

96.0

106 0

116.0

125 0 135.0

145 0

SOT Prefefehtial

Figure 5.7. SOT Preferential Histogram & P-P Plot o f PD Data.

Normal P-P Plot of ADT Toes Up

ADT Toes L)p

Observed Cum Prob

Figure J.8. ADT Toes UP (5' Attempt) Histogram & P-P Plot of PD Data.

97
NM7al P-B Rot of ADT Toes Down
6

4

2
std. Dev = 17.86

,*

Mean = 57.6
N=51.00

0
30.0

40.0

m.0

60.0

70.0

80.0

90.0

1W.O

ArJT Toes Down

Figure J.9. ADT Toes DOWN ( 5 Attempt)
~
Histogram & P-P Pb! af PD Data.

Normal P-P Plot of LQS Reactiarr-Timt

LOS Reaction Time

Observed Cum Prob

Figure J.10. LOS Reaction Time Histogram & P-P Plot of PD Data.

Noml P-P Plot of LOS Movement VE

LOS Movemeq ,tlocity
...A.

Observed Cum Prcb

I! 1%;

.

Figure J.11. LOS Movement Velocity His~ogram& P-P Plot of PD Data.

;- .
%

3-

.

Normal P-P Plot of LOS Endpoint Exct

15.0

.. . ..35.0

25.0

e.0

LOS Endpoint Exurrsion

65.0

86.0

75.0

85.0

Ohserved Cum R o b

.., ... .Figure 5.12. LOS Endpoint Excursion Histogram 6..P-P Plot of PD Data.

Norrna1.P-PP Iof~LOS Maximum Exc

\

1.

LOS Maxhwrn Excursion

Obsemd Cum Pro&

Figure 5.13. LOS Maximum Excursion Histogram & P-P Plot wf PD Data.

Normal P-P ?lot of LOS Directiowf Cc

LOS Directional Control

Observed Cum h o b

Figure 5.14. LOS DimAmal Control Histogram & P-P Plot of PD Data.

APPENDIX K

SAMPLE CALCULATIONS

All sample calculations use the SOT Composite test score as the example.

K. 1. Adiustinn NeuroCom Healthy Population Calculation.
:I

NeuroCom Healthy Population (AGES 60 - 69):
y, = 77.59
s, = 5.99
n, = 26
NeuroCom Healthy Population (AGES 70 - 79):
y , =72.85
3; <.
3, = 5.43
n , = 29

Adjusted NeuroCom Healthy Population (AGES 60 - 79):

K.2. Skewness and Kurtosis Value Calculation.
a = 0.05
Hypothesis:

Ho: Test Statistic falls within Skewness Critical Interval
Ha: Test Statistic does not fall within Skewness Critical intervfi

+

SkewnessValue = TestStatistic 1.96 x S tmdardDeviatiorz =: (-0.935) t- (1.96, :1< (0.333)
SkewnessValue = (-0.282,-1.588)

+

Kurtosis Value = TestStatistic 1.96 x S tarr dardDeviation = (0.302) f (1.96) x 10.656)
Kurtosis Value = (1.5 88,-2.8 1)

I

~3 :Equal Vaciaw Calculation: F-test.

a = 0.05
Hypothesis:

Ho: GI = 0 2 ,
Ha: 01 # 0 2

Parkinson's Disease Population:
S, =12.38
m=51
NeuroCom Healthy PopuWm (AGES 60 - 79):
S, = 5.65
n=55

Fobs

(4.797) > '(1-a

i2,m-l,nl-l)

(1.5787) . Therefore, we reject Ho. The sample

variance of the PD population is not equal to that of the healthy population, a = 0.05.

K.4. Simificant Difference Population Means Calculatioil: t-test,

a = 0.05
- ~ypcithesis: Ho: X 2 Y
Ha: X $ Y
Parkinson's Disease ~d$ulatic?h:
= 66.49
S, = 12.38
m=51
,

x

NeuroCom
Healthy Population (AGES 60 - 79):
Y = 75.09
S2 = 5.65
n=55

103

To,(-4.542) c Tdf=,,,(-1.6672) . There for, we reject Ho. The mean of the PD
'population is determined to be significantly less than the mean ofNeuroCom's healthy
:population, a = 0.05.
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